Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Clinical trial NCT05740566 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05740566
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2025-01-29
- Enrollment
- 509
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.